These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33340077)

  • 1. DNA integrity in diagnosis of premalignant lesions.
    Azab NA; Zahran FM; Amin AA; Rady NH
    Med Oral Patol Oral Cir Bucal; 2021 Jul; 26(4):e445-e450. PubMed ID: 33340077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.
    Gissi DB; Gabusi A; Tarsitano A; Asioli S; Rossi R; Marchetti C; Montebugnoli L; Foschini MP; Morandi L
    Cancer Biomark; 2020; 28(4):499-510. PubMed ID: 32568174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology of the oral cavity: a re-evaluation.
    Navone R
    Pathologica; 2009 Feb; 101(1):6-8. PubMed ID: 19771764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
    Kaur J; Politis C; Jacobs R
    Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of premalignant lesions and early cancers of the oral cavity.
    Gillenwater AM; Chambers MS
    Tex Dent J; 2006 Jun; 123(6):512-20. PubMed ID: 16875018
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of survivin in oral leukoplakia and oral lichen planus.
    Lalitha C; Hussain MK; Kodangal S; Swapna LA; Dantu R; Nagabhyrava P
    Minerva Dent Oral Sci; 2022 Jun; 71(3):125-130. PubMed ID: 34672483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How to improve the diagnostic and therapeutic levels of oral premalignant lesions].
    Zhou ZT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):89-91. PubMed ID: 15842851
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
    Rai B; Kaur J; Jacobs R; Singh J
    J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia.
    Yan SK; Wei BJ; Lin ZY; Yang Y; Zhou ZT; Zhang WD
    Oral Oncol; 2008 May; 44(5):477-83. PubMed ID: 17936673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of Helicobacter pylori in oral cavities of patients with leukoplakia and oral lichen planus.
    Kazanowska-Dygdała M; Duś I; Radwan-Oczko M
    J Appl Oral Sci; 2016; 24(1):18-23. PubMed ID: 27008253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
    Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
    J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diagnostic value of AgNOR and PAP in early detection of dysplastic changes in leukoplakia and lichen planus - a preliminary case-control study.
    Rao DS; Ali IM; Annigeri RG
    J Oral Pathol Med; 2017 Jan; 46(1):56-60. PubMed ID: 27238079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
    Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
    BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral cancer. Precancerous conditions].
    Vanclooster R
    Rev Belge Med Dent (1984); 1994; 49(1):23-33. PubMed ID: 7770650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA cytometry of oral leukoplakia and oral lichen planus.
    Femiano F; Scully C
    Med Oral Patol Oral Cir Bucal; 2005 Apr; 10 Suppl 1():E9-14. PubMed ID: 15800471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Not Available].
    Mollen I; Hitz Lindenmüller I; Lambrecht JT
    Praxis (Bern 1994); 2017 Jan; 106(1):21-27. PubMed ID: 28055317
    [No Abstract]   [Full Text] [Related]  

  • 19. [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders].
    Liu Y; Gao Y; Chen XJ; Hua H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):16-20. PubMed ID: 30773538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the miRNA-146a and miRNA-155 Expression Levels in Patients with Oral Lichen Planus.
    Ahmadi-Motamayel F; Bayat Z; Hajilooi M; Shahryar-Hesami S; Mahdavinezhad A; Samie L; Solgi G
    Iran J Immunol; 2017 Dec; 14(4):316-324. PubMed ID: 29276184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.